Literature DB >> 12190925

Perspective on antigen processing and presentation.

Emil R Unanue1.   

Abstract

The phenomenon of antigen processing and presentation and the concept that T cells recognize peptides resulting from the partial catabolism of proteins, are relatively new. These concepts were first recognized and developed at a time when lymphocyte immunity - the adaptive system - and cellular immunity, with its major component of activated macrophages, were not perceived as part of one integrated system. To me, it was the fundamental findings on the role of major histocompatibility (MHC) molecules that set the framework for understanding how phagocytes and the antigen presenting cell (APC) system interact with the adaptive cellular system, in a truly symbiotic relationship (1). In this chapter we make a historical review of the developments that, in my biased opinion, led to the understanding of antigen presentation as a central event. I emphasize my own work, placing it in my perspective of how I saw the field moving.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12190925     DOI: 10.1034/j.1600-065x.2002.18510.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  21 in total

1.  NADPH oxidase activity controls phagosomal proteolysis in macrophages through modulation of the lumenal redox environment of phagosomes.

Authors:  Joanna M Rybicka; Dale R Balce; Morgan F Khan; Regina M Krohn; Robin M Yates
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

2.  Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells.

Authors:  Alexei von Delwig; Julie A Musson; Joe Gray; Norman McKie; John H Robinson
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

3.  Immunity and protection, the unfolding of a tale.

Authors:  Maurizio Zanetti
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  Peritoneal macrophages suppress T-cell activation by amino acid catabolism.

Authors:  R Matlack; K Yeh; L Rosini; D Gonzalez; J Taylor; D Silberman; A Pennello; J Riggs
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

5.  Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling.

Authors:  Andreas Sturm; Klaus Rilling; Daniel C Baumgart; Konstantinos Gargas; Tay Abou-Ghazalé; Bärbel Raupach; Jana Eckert; Ralf R Schumann; Corinne Enders; Ulrich Sonnenborn; Bertram Wiedenmann; Axel U Dignass
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Effective antigen presentation to helper T cells by human eosinophils.

Authors:  Ruhaifah K Farhan; Mark A Vickers; Amir M Ghaemmaghami; Andrew M Hall; Robert N Barker; Garry M Walsh
Journal:  Immunology       Date:  2016-09-20       Impact factor: 7.397

7.  Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities.

Authors:  Robert Sealy; Wendy Chaka; Sherri Surman; Scott A Brown; Peter Cresswell; Julia L Hurwitz
Journal:  Clin Vaccine Immunol       Date:  2008-01-30

8.  Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules.

Authors:  Boris Calderon; Anish Suri; Mark J Miller; Emil R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-21       Impact factor: 11.205

9.  Human innate immune responses to hexamethylene diisocyanate (HDI) and HDI-albumin conjugates.

Authors:  A V Wisnewski; Q Liu; J Liu; C A Redlich
Journal:  Clin Exp Allergy       Date:  2008-06       Impact factor: 5.018

10.  Dual nature of the adaptive immune system in lampreys.

Authors:  Peng Guo; Masayuki Hirano; Brantley R Herrin; Jianxu Li; Cuiling Yu; Andrea Sadlonova; Max D Cooper
Journal:  Nature       Date:  2009-05-27       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.